| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049113074 |
| P356 | DOI | 10.1038/NATURE11605 |
| P3181 | OpenCitations bibliographic resource ID | 425715 |
| P698 | PubMed publication ID | 23051753 |
| P50 | author | George N. Khairallah | Q42849078 |
| Jérôme Le Nours | Q43376315 | ||
| Bronwyn S Meehan | Q55089356 | ||
| Lyudmila Kostenko | Q55297859 | ||
| Alexandra J. Corbett | Q55297861 | ||
| Ligong Liu | Q56765870 | ||
| Dale I Godfrey | Q56957983 | ||
| Jamie Rossjohn | Q28036336 | ||
| Lars Kjer-Nielsen | Q28036388 | ||
| James McCluskey | Q28355179 | ||
| Anthony W. Purcell | Q38523862 | ||
| David P. Fairlie | Q40192238 | ||
| Nicholas A. Williamson | Q40376378 | ||
| P2093 | author name string | Malcolm J McConville | |
| Onisha Patel | |||
| Zhenjun Chen | |||
| Richard A J O'Hair | |||
| Mugdha Bhati | |||
| Nadine L Dudek | |||
| Rangsima Reantragoon | |||
| P2860 | cites work | Structure of the human class I histocompatibility antigen, HLA-A2 | Q24297966 |
| Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor | Q24336313 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| MolProbity: all-atom contacts and structure validation for proteins and nucleic acids | Q24684673 | ||
| Interactions between the microbiota and the immune system | Q27028155 | ||
| The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization | Q27639867 | ||
| A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule | Q27643687 | ||
| Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope | Q27656096 | ||
| Structure of a Classical MHC Class I Molecule That Binds “Non-Classical” Ligands | Q27666285 | ||
| Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor | Q27678022 | ||
| Immune self-reactivity triggered by drug-modified HLA-peptide repertoire | Q27681301 | ||
| Specificity pockets for the side chains of peptide antigens in HLA-Aw68 | Q27700642 | ||
| Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
| Ultraviolet photodegradation of folic acid | Q46553167 | ||
| LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins | Q47687247 | ||
| Modulation of Valpha19 NKT cell immune responses by alpha-mannosyl ceramide derivatives consisting of a series of modified sphingosines. | Q51983654 | ||
| Fighting infection with your MAITs | Q56916832 | ||
| The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition | Q56917578 | ||
| Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 | Q59071944 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| The CCP4 suite: programs for protein crystallography | Q27861090 | ||
| The biology of NKT cells | Q28277482 | ||
| Host-gut microbiota metabolic interactions | Q29615104 | ||
| Where do MAIT cells fit in the family of unconventional T cells? | Q33425414 | ||
| Human mucosal associated invariant T cells detect bacterially infected cells | Q33627502 | ||
| Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface | Q33927547 | ||
| Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen | Q33960683 | ||
| Antimicrobial activity of mucosal-associated invariant T cells | Q34022899 | ||
| An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals | Q36367869 | ||
| MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells | Q36640043 | ||
| Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells | Q36745770 | ||
| HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides | Q36954248 | ||
| The fidelity, occasional promiscuity, and versatility of T cell receptor recognition | Q37110406 | ||
| MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution | Q37208551 | ||
| Antigen recognition by CD1d-restricted NKT T cell receptors. | Q37640899 | ||
| Mucosal-associated invariant T cells: unconventional development and function | Q37860732 | ||
| Biosynthesis of water-soluble vitamins | Q39901803 | ||
| Evidence for MR1 antigen presentation to mucosal-associated invariant T cells | Q40440555 | ||
| The crystal structure of human CD1d with and without alpha-galactosylceramide | Q42661990 | ||
| P433 | issue | 7426 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| 6,7-dimethyl-8-(1-D-ribityl)lumazine | Q4641523 | ||
| vitamin B | Q183206 | ||
| 7-hydroxy-6-methyl-8-(1-D-ribityl)lumazine | Q27103208 | ||
| reduced 6-(hydroxymethyl)-8-(1-D-ribityl)lumazine | Q27139232 | ||
| P304 | page(s) | 717-23 | |
| P577 | publication date | 2012-11-29 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | MR1 presents microbial vitamin B metabolites to MAIT cells | |
| P478 | volume | 491 |
| Q92784708 | 'Bohemian Rhapsody' of MR1T cells |
| Q44693283 | A 'GEM' of a cell |
| Q59341125 | A Co-culture Model of PBMC and Stem Cell Derived Human Nasal Epithelium Reveals Rapid Activation of NK and Innate T Cells Upon Influenza A Virus Infection of the Nasal Epithelium |
| Q92071899 | A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus |
| Q36119419 | A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule |
| Q55287219 | A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies. |
| Q41918765 | A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding Characteristics |
| Q35190832 | A comprehensive analysis of teleost MHC class I sequences |
| Q27678457 | A conserved human T cell population targets mycobacterial antigens presented by CD1b |
| Q27684762 | A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells |
| Q36160718 | A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains |
| Q35990524 | A nonclassical MHC class I U lineage locus in zebrafish with a null haplotypic variant |
| Q39157735 | A polymorphism in human MR1 is associated with mRNA expression and susceptibility to tuberculosis |
| Q38217703 | A prominent role for invariant T cells in the amphibian Xenopus laevis tadpoles |
| Q42084270 | A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin. |
| Q40499915 | A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. |
| Q37564579 | Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development |
| Q58556398 | Activates Human Mucosal-Associated Invariant T Cells |
| Q91997783 | Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma |
| Q90162887 | Activation and In Vivo Evolution of the MAIT Cell Transcriptome in Mice and Humans Reveals Tissue Repair Functionality |
| Q42270075 | Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. |
| Q38568857 | Activation of human T cells by CD1 and self-lipids. |
| Q90084055 | Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients |
| Q37697841 | Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus |
| Q36087086 | Activation, Impaired Tumor Necrosis Factor-α Production, and Deficiency of Circulating Mucosal-Associated Invariant T Cells in Patients with Scrub Typhus |
| Q36619693 | Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection |
| Q58563254 | Activity-Based Protein Profiling-Enabling Multimodal Functional Studies of Microbial Communities |
| Q38587715 | Adipose tissue inflammation in the pathogenesis of type 2 diabetes. |
| Q26998503 | Adoptive T Cell Therapy Targeting CD1 and MR1 |
| Q35018923 | Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics |
| Q99608499 | Alternative splicing of MR1 regulates antigen presentation to MAIT cells |
| Q37644275 | Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset |
| Q99711554 | Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries |
| Q101038988 | Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease |
| Q27680179 | Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells |
| Q38890709 | Are human iNKT cells keeping tabs on lipidome perturbations triggered by oxidative stress in the blood? |
| Q35752258 | Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection |
| Q90290433 | Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients |
| Q37649829 | Associations between serum folate and vitamin D levels and incident mouse sensitization in adults |
| Q37440890 | B cells modulate mucosal associated invariant T cell immune responses. |
| Q40120789 | Bacterial deception of MAIT cells in a cloud of superantigen and cytokines |
| Q90737346 | Bile Acid Profile and its Changes in Response to Cefoperazone Treatment in MR1 Deficient Mice |
| Q36770339 | Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1. |
| Q41996396 | Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria |
| Q98394885 | Boosting MAIT cells as immunotherapy: context is everything |
| Q28076184 | Brief review of the chicken Major Histocompatibility Complex: the genes, their distribution on chromosome 16, and their contributions to disease resistance |
| Q52738900 | Building conventions for unconventional lymphocytes. |
| Q27685257 | Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells |
| Q39029042 | Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system |
| Q50535290 | C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. |
| Q40059465 | CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells |
| Q34605938 | CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. |
| Q39098086 | CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner |
| Q26796132 | CD1d- and MR1-Restricted T Cells in Sepsis |
| Q27686847 | CD1d-lipid antigen recognition by the γδ TCR |
| Q47131315 | CD335 (NKp46)+ T-Cell Recruitment to the Bovine Upper Respiratory Tract during a Primary Bovine Herpesvirus-1 Infection |
| Q48648923 | CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis |
| Q64121498 | Casting a wider net: Immunosurveillance by nonclassical MHC molecules |
| Q36606978 | Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans |
| Q43851750 | Characterisation of non-classical MHC class I genes in the Tasmanian devil (Sarcophilus harrisii). |
| Q91432435 | Characterization and Purification of Mouse Mucosal-Associated Invariant T (MAIT) Cells |
| Q91432474 | Characterization of Human Mucosal-associated Invariant T (MAIT) Cells |
| Q57797176 | Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates |
| Q33630962 | Check MAIT. |
| Q92022466 | Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers |
| Q64228549 | Circulating Mucosal-Associated Invariant T Cells in a Large Cohort of Healthy Chinese Individuals From Newborn to Elderly |
| Q36536034 | Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients |
| Q34075150 | Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses |
| Q28066226 | Close Encounters of Lymphoid Cells and Bacteria |
| Q38062281 | Co-dependents: MR1-restricted MAIT cells and their antimicrobial function |
| Q26797242 | Coevolution of T-cell receptors with MHC and non-MHC ligands |
| Q33578547 | Commensal bacteria at the interface of host metabolism and the immune system |
| Q38713387 | Commensal gut bacteria modulate phosphorylation-dependent PPARγ transcriptional activity in human intestinal epithelial cells. |
| Q89171057 | Common ground: shared risk factors for type 1 diabetes and celiac disease |
| Q50134129 | Conservation of sequence motifs suggests that the nonclassical MHC class I lineages CD1/PROCR and UT were established before the emergence of tetrapod species. |
| Q52598286 | Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer. |
| Q38747458 | Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations. |
| Q27683716 | Crystallographic and kinetic study of riboflavin synthase fromBrucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility |
| Q37048910 | Current Knowledge and Future Research Directions on Fecal Bacterial Patterns and Their Association with Asthma |
| Q38303479 | Cytokine crowdsourcing: multicellular production of TH17-associated cytokines |
| Q42695808 | Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes |
| Q93047925 | DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade |
| Q35553709 | Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Acute Cholecystitis |
| Q37740450 | Deficiencies of Circulating Mucosal-associated Invariant T Cells and Natural Killer T Cells in Patients with Multiple Trauma. |
| Q92249413 | Deficiency of Mucosal-Associated Invariant T Cells in TCRJα18 Germline Knockout Mice |
| Q38170500 | Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells |
| Q59304306 | Development of mucosal-associated invariant T cells |
| Q47094084 | Dietary and Microbial Metabolites in the Regulation of Host Immunity |
| Q64062946 | Differences in the molecular signatures of mucosal-associated invariant T cells and conventional T cells |
| Q90183549 | Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease |
| Q88758055 | Directing T cell fate: How thymic antigen presenting cells coordinate thymocyte selection |
| Q54243192 | Distinct MHC class I-like interacting invariant T cell lineage at the forefront of mycobacterial immunity uncovered in Xenopus. |
| Q37016414 | Distinct activation thresholds of human conventional and innate-like memory T cells |
| Q64051873 | Diverse MR1-restricted T cells in mice and humans |
| Q47174198 | Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I-Related Molecule-Dependent and Cytokine-Driven Pathways. |
| Q64914702 | Does MHC heterozygosity influence microbiota form and function? |
| Q26768699 | Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma? |
| Q38922079 | Donor-unrestricted T cells in the human CD1 system |
| Q38717713 | Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. |
| Q92642986 | Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection |
| Q26800118 | Early innate responses to pathogens: pattern recognition by unconventional human T-cells |
| Q90627972 | Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms |
| Q40860044 | Editorial: CD1- and MR1-Restricted T Cells in Antimicrobial Immunity |
| Q92857778 | Editorial: Role of CD1- and MR1-Restricted T Cells in Immunity and Disease |
| Q66678733 | Elevated frequencies of total and MAIT cell subsets in patients with knee osteoarthritis |
| Q92886852 | Emerging roles of bile acids in mucosal immunity and inflammation |
| Q99593633 | Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens |
| Q27314968 | Endosomal MR1 Trafficking Plays a Key Role in Presentation of Mycobacterium tuberculosis Ligands to MAIT Cells |
| Q37101168 | Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells |
| Q36054037 | Enhanced Th1/Th17 Functions of CD161+ CD8+ T Cells in Mucosal Tissues of Rhesus Macaques. |
| Q37227889 | Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling |
| Q52668568 | Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma. |
| Q38883502 | Evolution of innate-like T cells and their selection by MHC class I-like molecules |
| Q34527136 | Evolution of nonclassical MHC-dependent invariant T cells |
| Q39228326 | Exceptionally high conservation of the MHC class I-related gene, MR1, among mammals. |
| Q64093795 | Expansion of IL-17A-secreting CD8 mucosa-associated invariant T cells in peripheral blood following stem cell mobilization |
| Q39673078 | Exploring the functions of nonclassical MHC class Ib genes in Xenopus laevis by the CRISPR/Cas9 system |
| Q39248532 | Expression and trafficking of MR1. |
| Q38804267 | Extensive Phenotypic Analysis, Transcription Factor Profiling, and Effector Cytokine Production of Human MAIT Cells by Flow Cytometry. |
| Q64912367 | Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells. |
| Q37334837 | FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri |
| Q47727880 | Folic acid prevented cognitive impairment in experimental pneumococcal meningitis |
| Q35815577 | Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. |
| Q89495082 | Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection |
| Q38852261 | Functional role of mucosal-associated invariant T cells in HIV infection. |
| Q38778174 | Functionally diverse human T cells recognize non-microbial antigens presented by MR1. |
| Q92784716 | Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 |
| Q91223925 | Graded diacylglycerol kinases α and ζ activities ensure mucosal-associated invariant T-cell development in mice |
| Q41986469 | Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation |
| Q92650360 | Gut Microbiome Biomarkers and Functional Diversity Within an Amazonian Semi-Nomadic Hunter-Gatherer Group |
| Q35170535 | Gut microbiota-generated metabolites in animal health and disease |
| Q36112685 | HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets |
| Q40147542 | HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8+ T cells |
| Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
| Q64051922 | Harnessing donor unrestricted T-cells for new vaccines against tuberculosis |
| Q58714915 | High MDR-1 expression by MAIT cells confers resistance to cytotoxic but not immunosuppressive MDR-1 substrates |
| Q38902093 | High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells |
| Q36351062 | Homeostatic Immunity and the Microbiota |
| Q89576459 | How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets |
| Q88587892 | How MAIT cells get their start |
| Q59355728 | Human MAIT cells are rapidly activated by Aspergillus spp. in an APC-dependent manner |
| Q37098070 | Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity |
| Q58697400 | Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity |
| Q37188416 | Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens |
| Q102144613 | Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer |
| Q50045500 | Human blood MAIT cell subsets defined using MR1 tetramers. |
| Q98222243 | Human endometrial MAIT cells are transiently tissue resident and respond to Neisseria gonorrhoeae |
| Q40093495 | Human mucosal-associated invariant T (MAIT) cells possess capacity for B-cell help |
| Q37247617 | Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation |
| Q89794792 | Human unconventional T cells in Plasmodium falciparum infection |
| Q52608541 | Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. |
| Q34157945 | ID'ing innate and innate-like lymphoid cells |
| Q40866100 | IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions |
| Q89948602 | IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia |
| Q49713185 | IL-7 treatment supports CD8+ MAIT cell restoration in HIV-1 infected patients on ART. |
| Q52717941 | IL13Rα2 expression identifies tissue-resident IL-22 producing PLZF+ innate T cells in the human liver. |
| Q36344921 | IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations |
| Q37271875 | Identification of a Potent Microbial Lipid Antigen for Diverse NKT Cells. |
| Q36069872 | Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer |
| Q35824188 | Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers |
| Q42129294 | Immune parameters to consider when choosing T-cell receptors for therapy |
| Q102379530 | Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells |
| Q56911915 | Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection |
| Q91820033 | Immunology of Mycobacterium tuberculosis Infections |
| Q52716582 | In Silico and Structural Analyses Demonstrate That Intrinsic Protein Motions Guide T Cell Receptor Complementarity Determining Region Loop Flexibility. |
| Q64258527 | Infant Complementary Feeding of Prebiotics for theMicrobiome and Immunity |
| Q52628809 | Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation. |
| Q45715422 | Innate Immune Recognition: Implications for the Interaction of Francisella tularensis with the Host Immune System |
| Q50034841 | Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine. |
| Q90559897 | Innate T cells in the intensive care unit |
| Q35947771 | Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms |
| Q48316500 | Innate immune cells for immunotherapy of autoimmune and cancer disorders. |
| Q34399419 | Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. |
| Q52654737 | Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes. |
| Q34075522 | Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised |
| Q55717169 | Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells. |
| Q91900309 | Interactions between Intestinal Microflora/Probiotics and the Immune System |
| Q96953883 | Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases? |
| Q52366720 | Interleukin-18 Is Critical for Mucosa-Associated Invariant T Cell Gamma Interferon Responses to Francisella Species In Vitro but Not In Vivo. |
| Q35912366 | Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis |
| Q40093638 | Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation |
| Q38169040 | Key roles of adjuvants in modern vaccines |
| Q57464740 | LFA-1 Ligation by High-Density ICAM-1 Is Sufficient To Activate IFN-γ Release by Innate T Lymphocytes |
| Q55408012 | Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells. |
| Q98735537 | Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies |
| Q42001435 | Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared amongst γδ T, Innate Lymphoid, and Th Cells |
| Q64934343 | Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells. |
| Q38590013 | Lipid and small-molecule display by CD1 and MR1. |
| Q58588189 | Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone |
| Q61797503 | Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions |
| Q99711502 | MAIT Cells at the Fetal-Maternal Interface During Pregnancy |
| Q27680211 | MAIT Recognition of a Stimulatory Bacterial Antigen Bound to MR1 |
| Q89505978 | MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight |
| Q48223629 | MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A. |
| Q34558727 | MAIT cell recognition of MR1 on bacterially infected and uninfected cells |
| Q38667181 | MAIT cells accumulate in placental intervillous space and display a highly cytotoxic phenotype upon bacterial stimulation |
| Q47551345 | MAIT cells and Viruses |
| Q49928718 | MAIT cells and microbial immunity. |
| Q38244066 | MAIT cells and pathogen defense |
| Q27469032 | MAIT cells are activated during human viral infections |
| Q47550378 | MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection |
| Q48254188 | MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation |
| Q37104082 | MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection |
| Q41687115 | MAIT cells are depleted early but retain functional cytokine expression in HIV infection |
| Q89506412 | MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis |
| Q34890728 | MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. |
| Q36338406 | MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications |
| Q58568564 | MAIT cells contribute to protection against lethal influenza infection in vivo |
| Q27332162 | MAIT cells detect and efficiently lyse bacterially-infected epithelial cells |
| Q89999319 | MAIT cells in metabolic diseases |
| Q48291527 | MAIT cells in type 1 diabetes: a good friend turned bad. |
| Q33817263 | MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immun |
| Q37415246 | MAIT cells promote inflammatory monocyte differentiation into dendritic cells during pulmonary intracellular infection. |
| Q58722526 | MAIT cells protect against pulmonary Legionella longbeachae infection |
| Q33390770 | MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation |
| Q28073095 | MAIT cells: new guardians of the liver |
| Q38890712 | MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? |
| Q46541186 | MAITs onstage in mice and men with three acts for development |
| Q26770048 | MHC and Evolution in Teleosts |
| Q38910293 | MR1 discovery |
| Q90101984 | MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage |
| Q64082742 | MR1 recycling and blockade of endosomal trafficking reveal distinguishable antigen presentation pathways between Mycobacterium tuberculosis infection and exogenously delivered antigens |
| Q90701082 | MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria |
| Q26852490 | MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases |
| Q93199363 | MR1-dependent antigen presentation |
| Q33964230 | MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage |
| Q27016137 | MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis |
| Q33580780 | MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates |
| Q39185888 | MR1B, a natural spliced isoform of the MHC-related 1 protein, is expressed as homodimers at the cell surface and activates MAIT cells |
| Q54224083 | MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron. |
| Q57286623 | Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis |
| Q54779554 | Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. |
| Q89030672 | Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment |
| Q94563407 | Massively parallel interrogation and mining of natively paired human TCRαβ repertoires |
| Q47116194 | Maternal nutritional status during pregnancy and infant immune response to routine childhood vaccinations |
| Q64076713 | Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells |
| Q34560345 | Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. |
| Q64105300 | Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity |
| Q37151353 | Metabolites: messengers between the microbiota and the immune system |
| Q35179505 | Metagenomic sequencing reveals altered metabolic pathways in the oral microbiota of sailors during a long sea voyage |
| Q99635125 | MicroRNA miR-181-A Rheostat for TCR Signaling in Thymic Selection and Peripheral T-Cell Function |
| Q34218508 | Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells |
| Q38935534 | Microbiota as a mediator of cancer progression and therapy. |
| Q90329866 | Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection |
| Q92283947 | Mining the microbiota for microbial and metabolite-based immunotherapies |
| Q35280550 | Modeling T cell receptor recognition of CD1-lipid and MR1-metabolite complexes |
| Q40061831 | Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity |
| Q88619078 | Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation |
| Q36153599 | Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study |
| Q47728419 | Molecular recognition of microbial lipid-based antigens by T cells. |
| Q34723826 | Molecules in medicine mini review: the αβ T cell receptor |
| Q36811942 | Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques |
| Q40097622 | Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment. |
| Q35558518 | Mucosal Immune Development in Early Life: Setting the Stage |
| Q92058744 | Mucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond |
| Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
| Q58748503 | Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells |
| Q36739969 | Mucosal associated invariant T cells: don't forget your vitamins |
| Q36014529 | Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies |
| Q91868533 | Mucosal-Associated Invariant T Cell Features and TCR Repertoire Characteristics During the Course of Multiple Sclerosis |
| Q49204780 | Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child |
| Q64234755 | Mucosal-Associated Invariant T Cell Levels Are Reduced in the Peripheral Blood and Lungs of Children With Active Pulmonary Tuberculosis |
| Q54963446 | Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease. |
| Q92239466 | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
| Q47194084 | Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation |
| Q90265871 | Mucosal-Associated Invariant T Cells Expressing the TRAV1-TRAJ33 Chain Are Present in Pigs |
| Q58764790 | Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization |
| Q92745001 | Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation |
| Q55301095 | Mucosal-Associated Invariant T Cells in Autoimmune Diseases. |
| Q54268263 | Mucosal-Associated Invariant T Cells in Chronic Inflammatory Liver Disease. |
| Q26781518 | Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out |
| Q47241753 | Mucosal-Associated Invariant T Cells in Regenerative Medicine |
| Q89613156 | Mucosal-Associated Invariant T Cells in Tumors of Epithelial Origin |
| Q47133613 | Mucosal-Associated Invariant T Cells: New Insights into Antigen Recognition and Activation |
| Q89519675 | Mucosal-Associated Invariant T cell in liver diseases |
| Q35408930 | Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients |
| Q35829274 | Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. |
| Q90514963 | Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome |
| Q91904779 | Mucosal-associated invariant T cells and disease |
| Q64060086 | Mucosal-associated invariant T cells and oral microbiome in persistent apical periodontitis |
| Q54969856 | Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. |
| Q38891491 | Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity |
| Q26750384 | Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases |
| Q26771558 | Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease |
| Q97692581 | Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity |
| Q40688729 | Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. |
| Q40100401 | Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis. |
| Q34305082 | Mucosal-associated invariant T-cells: new players in anti-bacterial immunity |
| Q39420793 | Multiple Sclerosis: Immunopathology and Treatment Update |
| Q33887115 | Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. |
| Q35245286 | Mycobacterium tuberculosis metabolism |
| Q46236111 | NKT cells: the smoking gun in fungal-induced asthma? |
| Q57171137 | Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections |
| Q91063214 | Neonatal intestinal immune regulation by the commensal bacterium, P. UF1 |
| Q92683823 | Neutrophils suppress mucosal-associated invariant T cells in humans |
| Q37124529 | Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis |
| Q36043783 | Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection |
| Q27007035 | Nonclassical T cells and their antigens in tuberculosis |
| Q50852086 | OMIP-021: Simultaneous quantification of human conventional and innate-like T-cell subsets. |
| Q54256962 | OMIP-046: Characterization of invariant T cell subset activation in humans. |
| Q92116605 | OMIP-058: 30-Parameter Flow Cytometry Panel to Characterize iNKT, NK, Unconventional and Conventional T Cells |
| Q48232467 | Ontogeny of human mucosal-associated invariant T cells and related T cell subsets |
| Q47180559 | Operational Experience of an Open-Access, Subscription-Based Mass Spectrometry and Proteomics Facility |
| Q42215094 | Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. |
| Q35016866 | Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. |
| Q57300020 | Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression |
| Q57107709 | Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells |
| Q37081221 | Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells |
| Q54214704 | Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotype. |
| Q64062638 | Qa-1-Restricted CD8 T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection |
| Q103028792 | Rab6 regulates recycling and retrograde trafficking of MR1 molecules |
| Q98735502 | Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies |
| Q54239585 | Recipient mucosal-associated invariant T cells control GVHD within the colon. |
| Q37088000 | Recognition of CD1d-restricted antigens by natural killer T cells |
| Q26795468 | Recognition of Microbial Glycolipids by Natural Killer T Cells |
| Q36381877 | Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells |
| Q27685209 | Recognition of vitamin B metabolites by mucosal-associated invariant T cells |
| Q40497285 | Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantation |
| Q64973520 | Recruitment of MAIT Cells to the Intervillous Space of the Placenta by Placenta-Derived Chemokines. |
| Q34439411 | Regional specialization within the intestinal immune system |
| Q26797333 | Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials |
| Q47744427 | Resolving the mystery of pyrophosphate antigen presentation |
| Q48194957 | Riboflavin Metabolism Variation Among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of MAIT Cells |
| Q58698386 | Role of CD1d- and MR1-Restricted T Cells in Asthma |
| Q34482936 | Role of Innate T Cells in Anti-Bacterial Immunity |
| Q63362830 | Role of MAIT cells in pulmonary bacterial infection |
| Q27026700 | Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus |
| Q57028269 | SOX4 controls invariant NKT cell differentiation by tuning TCR signaling |
| Q35671239 | STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function |
| Q39298329 | Sepsis and the innate-like response |
| Q40044893 | Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets. |
| Q52630399 | Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis. |
| Q42250131 | Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. |
| Q37692182 | Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells. |
| Q37421441 | Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae Infection |
| Q38905675 | Structure and function of the non-classical major histocompatibility complex molecule MR1. |
| Q58600234 | Structure of MHC class I-like MILL2 reveals heparan-sulfate binding and interdomain flexibility |
| Q48105713 | Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU). |
| Q35489763 | Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes |
| Q51813073 | T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes. |
| Q89965779 | T Cell Responses to Mycobacterial Glycolipids: On the Spectrum of "Innateness" |
| Q46254045 | T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells |
| Q26865650 | T cell recognition of non-peptidic antigens in infectious diseases |
| Q91822570 | T cells in severe childhood asthma |
| Q27689685 | T-cell activation by transitory neo-antigens derived from distinct microbial pathways |
| Q90162779 | TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions |
| Q37631857 | TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells |
| Q64968285 | TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis. |
| Q37522519 | Targeting Innate-Like T Cells in Tuberculosis. |
| Q94545285 | The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro |
| Q93159444 | The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool |
| Q52324313 | The Contribution of Non-Professional Antigen-Presenting Cells to Immunity and Tolerance in the Liver. |
| Q55399719 | The Conventional Nature of Non-MHC-Restricted T Cells. |
| Q59335043 | The Host Microbiota Contributes to Early Protection Against Lung Colonization by |
| Q99237890 | The Immune Modulating Properties of Mucosal-Associated Invariant T Cells |
| Q36709380 | The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator |
| Q26751427 | The Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence Outcome |
| Q41990094 | The MAIT conundrum - how human MAIT cells distinguish bacterial colonization from infection in mucosal barrier tissues |
| Q34662398 | The Maternal Serological Response to Intrauterine Ureaplasma sp. Infection and Prediction of Risk of Pre-Term Birth |
| Q57155753 | The Microbiome and Tuberculosis: Early Evidence for Cross Talk |
| Q60960298 | The Prenatal Microbiome: A New Player for Human Health |
| Q26798471 | The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity |
| Q38370910 | The T cell antigen receptor: the Swiss army knife of the immune system. |
| Q50638746 | The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells. |
| Q92579050 | The biology and functional importance of MAIT cells |
| Q38611633 | The burgeoning family of unconventional T cells |
| Q88575378 | The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus |
| Q97681303 | The dialogue between unconventional T cells and the microbiota |
| Q45894561 | The gut as a sensory organ. |
| Q37057724 | The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders |
| Q38780847 | The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1. |
| Q34708375 | The molecular bases of δ/αβ T cell-mediated antigen recognition. |
| Q27677529 | The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins |
| Q89984065 | The molecular basis underpinning the potency and specificity of MAIT cell antigens |
| Q38883507 | The role of MHC class Ib-restricted T cells during infection |
| Q39427595 | The role of MHC genes in contagious cancer: the story of Tasmanian devils |
| Q39089948 | The role of liver sinusoidal cells in local hepatic immune surveillance |
| Q38955495 | The role of mucosal-associated invariant T cells in infectious diseases |
| Q35883319 | The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research |
| Q49823694 | The versatility of the CD1 lipid antigen presentation pathway |
| Q37623478 | The versatility of the αβ T-cell antigen receptor |
| Q47100584 | Therapeutic vaccines for allergic disease |
| Q55365838 | Thymic Program Directing the Functional Development of γδT17 Cells. |
| Q96683869 | Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge |
| Q58102795 | Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17 |
| Q97541722 | Tissue-resident Mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset |
| Q33812840 | Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver |
| Q36358937 | Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors |
| Q27012749 | Transcriptional regulation of the NKT cell lineage |
| Q28390218 | Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool |
| Q49865220 | Tumor immunology viewed from alternative animal models-the Xenopus story |
| Q64100923 | Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules |
| Q90989324 | Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation |
| Q28087084 | Type 1 diabetes and gut microbiota: Friend or foe? |
| Q90683232 | Type I interferons are important co-stimulatory signals during T cell receptor mediated human MAIT cell activation |
| Q37229095 | Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling. |
| Q33035147 | Understanding the Apothecaries Within: The Necessity of a Systematic Approach for Defining the Chemical Output of the Human Microbiome |
| Q38315875 | Understanding the complexity and malleability of T-cell recognition |
| Q54217620 | Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. |
| Q26991896 | Universal immunity to influenza must outwit immune evasion |
| Q33897591 | Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae |
| Q57470612 | Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion |
| Q90044629 | Virus-Mediated Suppression of the Antigen Presentation Molecule MR1 |
| Q27348812 | Vitamin B2 as a virulence factor in Pseudogymnoascus destructans skin infection |
| Q37003147 | Vitamin-mediated regulation of intestinal immunity |
| Q42051386 | Vitamins as influenza vaccine adjuvant components |
| Q59081102 | Vitamins prime immunity |
| Q38809547 | What rheumatologists need to know about innate lymphocytes |
| Q37732225 | Will loss of your MAITs weaken your HAART [corrected]? |
| Q35632530 | αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features |
| Q26852046 | γδ T cell surveillance via CD1 molecules |
Search more.